Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBD does nothing for you? 6 reasons you can check

By

8 min readUpdated on

Feeling nothing from CBD is common, and six factors usually explain it: a product that does not contain what its label says, a dose far below those used in studies, the route of intake, timing, expectations shaped by THC, and your own body. CBD does not get you high, so a lack of sensation does not by itself point to a bad product. Feeling nothing is also a legitimate result.

Glass pipette above an open bottle, a drop about to fall

Key takeaways

  • Three French addiction monitoring centres found in 2023 that 8 CBD products in 10 did not match the content on their label.
  • EFSA's provisional safe level comes to about 2 mg a day for 70 kg, while the 2019 trial that measured an effect gave 300 mg at once.
  • How much swallowed CBD reaches the blood depends on food: up to 5 times more after a fatty meal than on an empty stomach.
  • A 2021 study showed that a CBD-free oil presented as "CBD oil" changed what people reported feeling.
  • Apart from Epidyolex, prescribed for rare forms of epilepsy, CBD is not a medicine.

1. The product does not contain what the label says

Start here, since this lead is the easiest to check. A press release of 19 June 2025 from the French agencies ANSES and ANSM cites a 2023 study by the addiction monitoring centres of Lyon, Paris and Montpellier. In it, 8 CBD products in 10 had a CBD content different from the one stated. In the United States, a study published in JAMA in 2017 analysed 84 products sold online. Only 31% were accurately labelled, and 26% contained less CBD than stated.

The same press release reports the reverse problem, which is more serious: products sold as CBD that held THC above 0.3% or synthetic cannabinoids. A strong effect from a "CBD" product is a warning sign and says nothing good about its quality.

You can check the certificate of analysis. It must carry the number of the batch you are holding, the measured CBD content and a Δ⁹-THC level no higher than 0.30%. Each line is explained in our guide on how to read a certificate of analysis.

2. The dose is far from those used in studies

On 9 February 2026, EFSA set a provisional safe intake of 0.0275 mg of CBD per kilo per day, which is about 2 mg for a 70 kg adult. The figure concerns CBD of at least 98% purity and excludes people under 25, pregnancy, breastfeeding and people on medication.

Work it out on a bottle. A 5% oil holds 50 mg of CBD per millilitre, and with a dropper giving about 20 drops per millilitre, each drop carries 2.5 mg. The number of drops per millilitre differs from one bottle to another, so check it on the leaflet.

The studies that measured an effect used far larger amounts. In a Brazilian trial published in 2019, 57 healthy men took 150, 300 or 600 mg of CBD, or a placebo, before a public speaking test. Only the 300 mg group reported less anxiety than the placebo group, and the 150 and 600 mg groups showed no difference.

Bars comparing 2 mg (EFSA level), 2.5 mg (one drop of 5% oil) and the single doses of 150, 300 and 600 mg from a 2019 trial
Milligrams of CBD. Sources: EFSA, 2026; Linares et al., Brazilian Journal of Psychiatry, 2019

Do not read this chart as a dosage guide. It shows that one drop cannot be expected to do what a trial saw with 120 times more. It also shows that the relationship is not linear, and that a higher dose does not give a better result, as our article on CBD's biphasic effect describes. Above EFSA's level, talk to a doctor. Epidyolex, the only authorised CBD-based medicine, is prescribed under medical supervision, with doses calculated by body weight.

3. The route of intake changes what reaches the blood

The orders of magnitude come from a 2018 systematic review of CBD pharmacokinetics in humans:

RouteBlood peak (Tmax)What the review reports
Inhaled (smoked)About 15 minutes in one studyAverage bioavailability of 31% in the study that measured it
Spray on the lining of the mouth1.64 to 4.2 hoursNo absolute bioavailability measured
SwallowedMostly 1 to 4 hoursArea under the curve 5 times higher and peak 3 times higher after a meal than fasting, in the study cited

Two practical points follow. An oil swallowed on an empty stomach may hardly reach the blood, and two tries made in two different ways tell you nothing about the product. As for the French framework, on 20 May 2026 the Ministry of Agriculture stated that foods containing CBD are illegal and must be withdrawn from the market. Our article on the sublingual route describes the technique and recommends no food use.

4. Timing: a peak in hours, a steady level in days

Many people judge after a single dose. A swallowed dose only peaks in the blood one to four hours later, though, and the blood level settles after several days of regular intake. These delays are detailed in our article on how long CBD takes to work. The window of four to six weeks often quoted for judging a product is a usage convention, with no scientific standard behind it.

5. You expect an effect CBD does not produce

CBD causes no intoxication, no euphoria and no change in perception. MILDECA, France's interministerial drug agency, notes that unlike THC it causes no dependence, and that no CBD product may claim a therapeutic effect without a medicine authorisation. If you expect the feeling of a joint, you will always conclude that "it does not work". The reason is explained in our article does CBD get you high.

Expectation can also act in the opposite direction. In a Canadian study from 2021, 43 adults received a CBD-free hempseed oil on two occasions, and on one of them they were told it contained CBD. That day they reported feeling more sedated, and the participants most convinced that CBD helps with anxiety reported less anxiety. Part of what you feel is what you expect.

6. Your body and the context

The liver breaks CBD down with the same enzymes as many medicines, which opens the way to the interactions described in our article on the grapefruit effect. Body weight, meals, sleep, alcohol and fatigue all affect what you perceive. Because CBD may cause drowsiness, the 2025 ANSES and ANSM press release advises drivers and workers exposed to risks against it. It also warns that CBD can alter the effect of some medicines. If you take any treatment, ask your doctor or pharmacist.

Running an honest trial: five rules

To find out whether a product does anything for you, change one thing at a time and keep everything else fixed.

RuleWhy
One product, one batchThe next batch may have a different content
Same amount, same time, same timing relative to mealsMeals change how much reaches the blood
A dated log: amount in mg, sleep, coffee, alcoholWithout a written record, memory rebuilds the story
At least two weeks before concludingThe blood level takes several days to stabilise
Stay below EFSA's level without medical adviceSafety above it is not established

If nothing changes, three conclusions are possible: switch format, for example a CBD flower rather than an oil, check another analysed batch, or conclude that CBD does nothing for you. Each of the three is a valid answer.

Frequently asked questions

Usually for one of these reasons: an actual content below the label, a dose of a few milligrams, intake on an empty stomach, a verdict reached too early, or the expectation of a THC-type effect. CBD produces no psychoactive high, so feeling nothing is normal.

Without medical advice, do not go beyond EFSA's level of about 2 mg a day for 70 kg. Study doses run to hundreds of milligrams and belong in a research setting, with no place in everyday use. A 2019 trial even saw no effect at 600 mg, where 300 mg had one.

Not necessarily. ANSES and ANSM have reported poisonings from products sold as CBD that held THC above 0.3% or synthetic cannabinoids. If the effect is marked, check the batch certificate.

No study supports that claim. Whether cannabinoids and terpenes produce an entourage effect is still debated, as our article on the entourage effect explains.


Written by the Phytogrammes team

Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.

Article published on . CBD is not a medicine.